FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029385923> ?p ?o ?g. }

• W2029385923 endingPage "695" @default.
• W2029385923 startingPage "688" @default.
• W2029385923 abstract "Liver transplant recipients at high risk for serious fungal infections frequently receive fluconazole or an amphotericin B preparation for antifungal prophylaxis. Because of concerns about fungal resistance with fluconazole, safety with amphotericin B, and the cost of lipid formulations of amphotericin, alternative prophylactic regimens are needed. In this randomized, controlled trial, we compared the efficacy and safety of oral itraconazole solution with intravenous/oral fluconazole for prevention of fungal infections.Adult liver transplant recipients were randomized to receive either oral itraconazole solution (200 mg every 12 hr) or intravenous/oral fluconazole (400 mg every 24 hr). Each study drug was started immediately before transplant surgery and continued for 10 weeks after transplantation. Patients were evaluated for fungal colonization, proven invasive or superficial fungal infection, drug-related side effects, and death.Fungal colonization decreased from baseline to week 8 after transplantation in both the itraconazole patients (67% to 25%, P<0.001) and the fluconazole patients (77% to 30%, P<0.001). Proven fungal infection developed in 9 (9%) of 97 itraconazole patients and in 4 (4%) of 91 fluconazole patients (P =0.25). The number of proven invasive fungal infections (seven with itraconazole [7%], three with fluconazole [3%]) and proven superficial fungal infections (two with itraconazole [2%], one with fluconazole [1%]) were also similar in both groups of patients. Organisms causing infection were (four patients), (three patients), and species (two patients) in the itraconazole group and (two patients), (one patient), and species (one patient) in the fluconazole group. Mortality from fungal infection was very low and occurred in only 1 (0.5%) of 188 patients. Except for more frequent gastrointestinal side effects (nausea, vomiting, diarrhea) with itraconazole, both itraconazole and fluconazole were well tolerated and not associated with any hepatotoxicity. Mean trough plasma concentrations of itraconazole were greater than 250 ng/mL throughout the study and were not affected by H -receptor antagonists or antacids.Oral itraconazole solution has adequate bioavailability in liver transplant recipients for effective antifungal prophylaxis. Similar to fluconazole, prophylactic oral itraconazole decreases fungal colonization and is associated with a low incidence of serious or fatal fungal infections. Except for gastrointestinal side effects, oral itraconazole solution is well tolerated and has no significant hepatotoxicity." @default.
• W2029385923 created "2016-06-24" @default.
• W2029385923 creator A5004106499 @default.
• W2029385923 creator A5075909338 @default.
• W2029385923 date "2002-09-01" @default.
• W2029385923 modified "2023-09-25" @default.
• W2029385923 title "Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients1" @default.
• W2029385923 cites W1975032332 @default.
• W2029385923 cites W1976927311 @default.
• W2029385923 cites W1989277463 @default.
• W2029385923 cites W1993517065 @default.
• W2029385923 cites W1995337263 @default.
• W2029385923 cites W2020985135 @default.
• W2029385923 cites W2028641895 @default.
• W2029385923 cites W2047526581 @default.
• W2029385923 cites W2051923223 @default.
• W2029385923 cites W2061748969 @default.
• W2029385923 cites W2065419430 @default.
• W2029385923 cites W2069014723 @default.
• W2029385923 cites W2069716936 @default.
• W2029385923 cites W2070762099 @default.
• W2029385923 cites W2077497174 @default.
• W2029385923 cites W2081607015 @default.
• W2029385923 cites W2084770271 @default.
• W2029385923 cites W2096480959 @default.
• W2029385923 cites W2099050265 @default.
• W2029385923 cites W2105749407 @default.
• W2029385923 cites W2107471693 @default.
• W2029385923 cites W2115907078 @default.
• W2029385923 cites W2122570253 @default.
• W2029385923 cites W2127288395 @default.
• W2029385923 cites W2132463351 @default.
• W2029385923 cites W2142418809 @default.
• W2029385923 cites W2145573601 @default.
• W2029385923 cites W2154317994 @default.
• W2029385923 cites W2157428610 @default.
• W2029385923 cites W2341266869 @default.
• W2029385923 cites W280672004 @default.
• W2029385923 cites W4293241248 @default.
• W2029385923 cites W4322388204 @default.
• W2029385923 doi "https://doi.org/10.1097/00007890-200209150-00017" @default.
• W2029385923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12352887" @default.
• W2029385923 hasPublicationYear "2002" @default.
• W2029385923 type Work @default.
• W2029385923 sameAs 2029385923 @default.
• W2029385923 citedByCount "90" @default.
• W2029385923 countsByYear W20293859232012 @default.
• W2029385923 countsByYear W20293859232013 @default.
• W2029385923 countsByYear W20293859232014 @default.
• W2029385923 countsByYear W20293859232015 @default.
• W2029385923 countsByYear W20293859232016 @default.
• W2029385923 countsByYear W20293859232017 @default.
• W2029385923 countsByYear W20293859232018 @default.
• W2029385923 countsByYear W20293859232019 @default.
• W2029385923 countsByYear W20293859232020 @default.
• W2029385923 countsByYear W20293859232021 @default.
• W2029385923 countsByYear W20293859232022 @default.
• W2029385923 crossrefType "journal-article" @default.
• W2029385923 hasAuthorship W2029385923A5004106499 @default.
• W2029385923 hasAuthorship W2029385923A5075909338 @default.
• W2029385923 hasConcept C126322002 @default.
• W2029385923 hasConcept C141071460 @default.
• W2029385923 hasConcept C16005928 @default.
• W2029385923 hasConcept C168563851 @default.
• W2029385923 hasConcept C2777071850 @default.
• W2029385923 hasConcept C2779548794 @default.
• W2029385923 hasConcept C2779629538 @default.
• W2029385923 hasConcept C2780651595 @default.
• W2029385923 hasConcept C2780908437 @default.
• W2029385923 hasConcept C2911091166 @default.
• W2029385923 hasConcept C2991737395 @default.
• W2029385923 hasConcept C71924100 @default.
• W2029385923 hasConcept C90924648 @default.
• W2029385923 hasConceptScore W2029385923C126322002 @default.
• W2029385923 hasConceptScore W2029385923C141071460 @default.
• W2029385923 hasConceptScore W2029385923C16005928 @default.
• W2029385923 hasConceptScore W2029385923C168563851 @default.
• W2029385923 hasConceptScore W2029385923C2777071850 @default.
• W2029385923 hasConceptScore W2029385923C2779548794 @default.
• W2029385923 hasConceptScore W2029385923C2779629538 @default.
• W2029385923 hasConceptScore W2029385923C2780651595 @default.
• W2029385923 hasConceptScore W2029385923C2780908437 @default.
• W2029385923 hasConceptScore W2029385923C2911091166 @default.
• W2029385923 hasConceptScore W2029385923C2991737395 @default.
• W2029385923 hasConceptScore W2029385923C71924100 @default.
• W2029385923 hasConceptScore W2029385923C90924648 @default.
• W2029385923 hasIssue "5" @default.
• W2029385923 hasLocation W20293859231 @default.
• W2029385923 hasLocation W20293859232 @default.
• W2029385923 hasOpenAccess W2029385923 @default.
• W2029385923 hasPrimaryLocation W20293859231 @default.
• W2029385923 hasRelatedWork W109538737 @default.
• W2029385923 hasRelatedWork W1995509811 @default.
• W2029385923 hasRelatedWork W2029385923 @default.
• W2029385923 hasRelatedWork W2039034599 @default.
• W2029385923 hasRelatedWork W2054658280 @default.
• W2029385923 hasRelatedWork W2108386026 @default.
• W2029385923 hasRelatedWork W2132088754 @default.

• next